GRETCHEN MCCABE: Open Payments
NPI 1780002899 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 27 payments from 11 companies in 2025. Trend: 2023 $670 · 2024 $805 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $200 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $92 |
| Janssen Biotech, Inc. | 4 | $90 |
| LEO Pharma Inc. | 2 | $47 |
| UCB, Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $35 |
| Incyte Corporation | 1 | $26 |
| Galderma Laboratories, L.P. | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
Products named: COSENTYX, ILUMYA, TREMFYA, DUPIXENT, ANZUPGO, Bimzelx, RINVOQ, Rhapsido.
Industry payments across KY — which companies pay providers there.
